Mielóma multiplex: vizsgálatok itt: Egyesült Királyság
48 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
- Where
- Birmingham, Bristol, Glasgow, Scotland, London
- Életkor
- 18 év and over
- People
- 508 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07391657 - 2. fázisTaking peopleA Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
- Where
- Belfast, Colchester, Eastbourne, Liverpool, London, Manchester, Newcastle upon Tyne
- Életkor
- 18 év and over
- People
- 210 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06500884 · EU 2023-506260-14-00 - 2. fázisCsak meghívásosLong-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells
- Where
- Glasgow, London, Manchester, Newcastle upon Tyne
- Életkor
- 1 év and over
- People
- 500 worldwide
- Run by
- Autolus Limited
See details and how to joinNCT03628612 - 2. fázisTaking peopleInobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma
- Where
- Bebington, Cardiff, Edinburgh, London, Oxford, Southampton, Sutton, Withington
- Életkor
- 18 év and over
- People
- 100 worldwide
- Run by
- CellCentric Ltd.
See details and how to joinNCT07096778 - No phaseNot yet taking people in Egyesült KirályságREal World MAIA UK OutcomEs
- Where
- Wolverhampton
- Életkor
- 18 év and over
- People
- 300
- Run by
- The Royal Wolverhampton Hospitals NHS Trust
See details and how to joinNCT07532473 - 1/2. fázisTaking peopleA Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
- Where
- London, Manchester
- Életkor
- 18 év and over
- People
- 62 worldwide
- Run by
- Celgene
See details and how to joinNCT06988488 · EU 2025-522090-11-00 - No phaseTaking peopleA Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials
- Where
- Birmingham, London, Wolverhampton
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Janssen-Cilag Ltd.
See details and how to joinNCT06285318 - 3. fázisFut, nem toborozA Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
- Where
- Bournemouth, Bristol, Canterbury, Cardiff, Manchester, Oxford
- Életkor
- 18 év and over
- People
- 893 worldwide
- Run by
- Pfizer
See details and how to joinNCT05020236 · EU 2023-509208-14-00 - 1/2. fázisTaking peopleA Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
- Where
- Leicester, Oxford, Plymouth
- Életkor
- 18 év and over
- People
- 123 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT05714839 · EU 2022-501941-63-00 - 1/2. fázisTaking peopleA Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
- Where
- London, Manchester
- Életkor
- 18 év and over
- People
- 220 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06292780 · EU 2023-507809-34-00 - 2/3. fázisTaking peopleDETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.
- Where
- Belfast, Birmingham, Bristol, Cambridge, Cardiff, Edinburgh, Glasgow, Leicester, Liverpool, London, Manchester, Metropolitan Borough of Wirral, Newcastle, Oxford, Sheffield, Southampton, Sutton
- Életkor
- 1 év and over
- People
- 30
- Run by
- Cancer Research UK
See details and how to joinNCT07440290 - 3. fázisNot yet taking people in Egyesült KirályságStudy of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
- Where
- Edinburgh, London, Manchester
- Életkor
- 18 év and over
- People
- 750 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07764978 - 1/2. fázisTaking peopleA Study to Assess the Safety and Anti-Tumor Activity of REGN7945 in Combination With Linvoseltamab in Adult Participants With Relapsed/Refractory Multiple Myeloma
- Where
- London, Manchester
- Életkor
- 18 év and over
- People
- 186 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06669247 · EU 2024-513126-39-00 - 1/2. fázisTaking peopleStudy to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
- Where
- Bebington, Bristol, Cardiff, Derby, Edinburgh, Glasgow, Leicester, London, Manchester, Newcastle upon Tyne, Nottingham, Oxford, Southampton, Stoke-on-Trent, Sutton
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- CellCentric Ltd.
See details and how to joinNCT04068597 - 2. fázisTaking peopleMethods of T Cell Depletion Trial (MoTD)
- Where
- Birmingham, Bristol, Cambridge, Cardiff, Glasgow, Leeds, London, Manchester, Newcastle upon Tyne, Nottingham, Oxford, Plymouth, Sheffield, Sutton
- Életkor
- 16 év to 70 év
- People
- 400
- Run by
- University of Birmingham
See details and how to joinNCT04888741 - 3. fázisTaking peopleA Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
- Where
- Leicester, Middlesbrough, Oxford, Plymouth, Wolverhampton
- Életkor
- 18 év and over
- People
- 520 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06679101 · EU 2024-516030-35-00 - No phaseTaking peopleZn-DDC to Target Hypoxia-NFkappaB-CSCs Pathway in Multiple Myeloma
- Where
- Wolverhampton
- Életkor
- 18 év and over
- People
- 70
- Run by
- The Royal Wolverhampton Hospitals NHS Trust
See details and how to joinNCT04234022 - 1/2. fázisTaking peopleA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Birmingham, Bristol, Edinburgh, London, Manchester, Oxford, Stoke-on-Trent, Sutton
- Életkor
- 12 év and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555 - 2/3. fázisTaking peopleDETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.
- Where
- Belfast, Birmingham, Bristol, Cambridge, Cardiff, Edinburgh, Glasgow, Leicester, London, Manchester, Metropolitan Borough of Wirral, Newcastle, Oxford, Sheffield, Southampton
- Életkor
- 18 év and over
- People
- 30
- Run by
- Cancer Research UK
See details and how to joinNCT05768178 - 1. fázisTaking peopleA New Study Evaluating the Activity of Modular CAR T for mYeloma
- Where
- London
- Életkor
- 18 év and over
- People
- 27
- Run by
- University College, London
See details and how to joinNCT04795882 - 1/2. fázisTaking peopleA Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
- Where
- Leicester, Liverpool, London, Manchester, Oxford
- Életkor
- 18 év and over
- People
- 260 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT05372354 · EU 2023-509384-25-00 - No phaseTaking peopleMyeloma Novel Drug Discovery Ver 1.2
- Where
- Sutton
- Életkor
- 18 év and over
- People
- 250
- Run by
- Institute of Cancer Research, United Kingdom
See details and how to joinNCT05968417 - 3. fázisTaking peopleThe Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)
- Where
- Aberdeen, Airdrie, Ayr, Barnsley, Basingstoke, Bath, Birmingham, Blackpool, Boston, Bournemouth, Bradford, Bristol, Burton-on-Trent, Cambridge, Carshalton, Cheltenham, Chester, Chesterfield, Chichester, Coventry, Derby, Dewsbury, Dudley, Dundee, East Kilbride, Edinburgh, Glasgow, Gloucester, Grantham, Grimsby, Halifax, Harrogate, Huddersfield, Hull, Inverness, Ipswich, Kidderminster, Kilmarnock, Leeds, Leicester, Lincoln, Liverpool, London, Maidstone, Manchester, Melrose, Middlesbrough, Milton Keynes, Newcastle, North Shields, Norwich, Nottingham, Oldham, Oxford, Paisley, Plymouth, Pontefract, Prescot, Reading, Redditch, Royal Tunbridge Wells, Salford, Salisbury, Scunthorpe, Sheffield, Southampton, Stafford, St Helens, Stockport, Stoke-on-Trent, Sunderland, Sutton in Ashfield, Swansea, Taunton, Tooting, Wakefield, Winchester, Wishaw, Wolverhampton, Worcester, Worthing
- Életkor
- 18 év and over
- People
- 406
- Run by
- University of Leeds
See details and how to joinNCT03562169